No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial

In a comparative conventional MRI, dynamic contrast-enhanced (DCE)-MRI, CT and radiography study, the authors aimed to monitor whether inflammation is reduced or even eliminated and damage halted in PsA patients receiving anti-TNF therapy. A 48-week prospective open-label investigator-initiated tria...

Full description

Saved in:

Bibliographic Details
Published in:	Rheumatology (Oxford, England) Vol. 53; no. 4; pp. 746 - 756
Main Authors:	Poggenborg, René Panduro, Wiell, Charlotte, Bøyesen, Pernille, Boonen, Annelies, Bird, Paul, Pedersen, Susanne Juhl, Sørensen, Inge Juul, Madsen, Ole Rintek, Slot, Ole, Møller, Jakob M, Hasselquist, Maria, Kubassova, Olga, Østergaard, Mikkel
Format:	Journal Article
Language:	English
Published:	England 01-04-2014
Subjects:	Adalimumab Adult Anti-Inflammatory Agents - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Arthritis, Psoriatic - diagnostic imaging Arthritis, Psoriatic - drug therapy Arthritis, Psoriatic - pathology Disease-Free Survival Female Hand Joints - diagnostic imaging Hand Joints - pathology Humans Magnetic Resonance Imaging Male Middle Aged Prospective Studies Synovitis - diagnostic imaging Synovitis - drug therapy Synovitis - pathology Tomography, X-Ray Computed Treatment Outcome computed tomography magnetic resonance imaging biologic therapy psoriatic arthritis radiography
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!